supply of - inj semaglutide 0.25mg , inj semaglutide 0 point 5mg , inj semaglutide 1 point 0 mg , inj semaglutide 1 point 7 mg , inj tirzepatide 2 point 5mg per 0 point 6ml in multidose prefilled pen , inj tirzepatide 5 point 0mg 0 point 6ml in multidose prefilled pen , inj tirzepatide 7 point 5 mg per 0 point 6ml in multidose prefilled pen , inj tirzepatide 10 point 0 mg per 0 point 6ml in multidose prefilled pen , inj tirzepatide 12 point 5 mg per 0 point 6ml in multidose prefilled pen , insul

Indian Army has invited bids for the supply of - inj semaglutide 0.25mg , inj semaglutide 0 point 5mg , inj semaglutide 1 point 0 mg , inj semaglutide 1 point 7 mg , inj tirzepatide 2 point 5mg per 0 point 6ml in multidose prefilled pen , inj tirzepatide 5 point 0mg 0 point 6ml in multidose prefilled pen , inj tirzepatide 7 point 5 mg per 0 point 6ml in multidose prefilled pen , inj tirzepatide 10 point 0 mg per 0 point 6ml in multidose prefilled pen , inj tirzepatide 12 point 5 mg per 0 point 6ml in multidose prefilled pen , insulin human inhalatation powder r dna 4 units , insulin human inhalatation powder r dna 8 units , insulin human inhalatation powder r dna 12 units , inj romosozumab 105mg per 1 point 17ml , testosterone propionate 250 mg inj , insulin lispro 100 iu per ml inj humalog junior kwik pen 3ml solution for inj in a prefilled pen 0 point 5 unit dose dialing , inj human growth hormone somatropin 04 iu , inj denosumab 60 mg per ml - rd 203 | quantity - 1468.. Please refer to the tender document for project value and EMD details. Interested bidders can submit applications until 29 September 2026, with the technical opening scheduled for 29 September 2026.